drugset / Trial / NCT02179866

A Single-center Study to Investigate How Quickly and to What Extent a Radioactive Dose of RO5285119 is Absorbed, Metabolized and Eliminated From the Body of Healthy Male Volunteers

NCT02179866

Phase 1 Completed 6 enrolled Hoffmann-La Roche
Non-randomizedSingle-groupOpen-label

Summary

This study is designed to investigate the absorption, distribution, metabolism and elimination of a single oral dose of radiolabeled \[14C\]-labeled RO5285119 in healthy male participants.

Timeline

Start
2014-06
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Balovaptan Small molecule 2.1 mbq Oral

Indications

No indication recorded.